1st Feb 2016 15:41
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibilities or Connected Persons
The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the 'Plan') notified GlaxoSmithKline plc ('GSK') on 28 January 2016 that the under-mentioned Directors, Persons Discharging Managerial Responsibilities ('PDMR') and Connected Persons acquired notional Ordinary Shares at a price of 1380.50 pence per Ordinary Share and American Depositary Shares ('ADSs') at a price of $40.28 per ADS, following the notional re-investment of the dividend paid to shareholders on 14 January 2016.
Director/PDMR | Ordinary Shares | ADSs |
Sir Andrew Witty | 19,386.598 | |
Dr M M Slaoui | 5,593.782 | |
Mr S Dingemans | 8,420.745 | |
Mr R G Connor | 3,776.009 | |
Mr N Hirons | 605.055 | 205.414 |
Mr S A Hussain | 7,915.467 | |
Mr D S Redfern | 2,871.479 | |
Ms C Thomas | 3,990.411 | |
Mr P C Thomson | 2,037.648 | |
Mr D E Troy | 3,479.925 | |
Dr P J T Vallance | 8,497.018 | |
Ms E Walmsley | 5,746.265 | |
Mrs V A Whyte | 535.716 |
Connected Person |
Ordinary Shares |
ADSs |
Dr K Slaoui (Connected Person to Dr M M Slaoui) | 90.488 | |
Mrs K Thomson (Connected Person to Mr P C Thomson) | 50.565 |
The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
1 February 2016
Related Shares:
Glaxosmithkline